FDA Okays New PAD Indication for Rivaroxaban (Xarelto) ...Middle East

The FDA okays an expanded PAD indication for rivaroxaban to include patients who have undergone lower-extremity revascularization for PAD, based on the VOYAGER-PAD and COMPASS trials. FDA Approvals

Hence then, the article about fda okays new pad indication for rivaroxaban xarelto was published today ( Wednesday 25/08/2021 - 12:00 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays New PAD Indication for Rivaroxaban (Xarelto) )

Also on site :

• MSP vs ING Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- Legends League Cricket 2026, Match 4
• Best AI Course Online (2026): Coursera Named Go-To Platform for Artificial Intelligence Training by Consumer365
• Yes, companies can stay profitable without raising prices — here’s how